Skip to content

13F-HR filed by Eversept Partners, LP

Eversept Partners, LP filed this 13F-HR for the quarter ended 2018-12-31, filed 2019-02-13, with 59 holding rows worth $180,696,000.

Accession
0001697013-19-000003
Filed
2019-02-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2018

A holdings report, 59 entries on the cover page, a total value of $180,696,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $180,696,000 with VALUE read as thousands by filing date, 13F file number 028-18369. A later restatement replaced it, so the quarter does not use it. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ZOGENIX INC.98978L204Common Stock563,429$20,543,000thousands by filing date
GLAXOSMITHKLINE PLC-ADR37733W105SPONSORED ADR529,484$20,392,000thousands by filing date
R1 RCM INC749397105COM2,349,306$18,677,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW1,263,407$17,195,000thousands by filing date
SANOFI SA SPONSORED ADR80105N105ADR306,242$13,294,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW552,053$9,103,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM232,790$8,404,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM36,492$6,047,000thousands by filing date
Danaher Corporation235851102COM47,804$4,937,000thousands by filing date
ABIOMED INC003654100COM13,939$4,531,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM40,494$4,419,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR38,224$3,672,000thousands by filing date
Merck & Co.,Inc.58933Y105COM45,800$3,528,000thousands by filing date
ENSIGN GROUP INC29358P101COM85,575$3,323,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW81,371$3,169,000thousands by filing date
TELIGENT INC NEW87960W104COM2,247,476$3,079,000thousands by filing date
TESARO INC881569107COM36,000$2,673,000thousands by filing date
Abbott Laboratories002824100COM31,400$2,271,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM165,000$2,117,000thousands by filing date
QIAGEN NVN72482123SHS NEW55,300$1,905,000thousands by filing date
ILLUMINA INC452327109COM5,148$1,544,000thousands by filing date
GENOMIC HEALTH, INC.37244C101COM23,866$1,537,000thousands by filing date
MYLAN NVN59465109SHS EURO55,000$1,507,000thousands by filing date
DECIPHERA PHARMACEUTICALS IN24344T101COM69,700$1,463,000thousands by filing date
APELLIS PHARMACEUTICALS INC03753U106COM106,880$1,410,000thousands by filing date
LOXO ONCOLOGY INC548862101COM10,000$1,401,000thousands by filing date
BIOSPECIFICS TECHNOLOGIES090931106COM22,000$1,333,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock163,959$1,323,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock205,104$1,294,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock90,412$1,288,000thousands by filing date
FOAMIX PHARMACEUTICALS LTDM46135105SHS294,660$1,058,000thousands by filing date
AFFIMED N VN01045108COM335,774$1,044,000thousands by filing date
CARETRUST REIT INC COM14174T107REIT51,264$956,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR15,254$956,000thousands by filing date
TRICIDA INC89610F101COM40,522$956,000thousands by filing date
ARQULE INC04269E107COM344,618$955,000thousands by filing date
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK42,301$861,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM8,271$792,000thousands by filing date
Elevance Health, Inc.036752103COM2,300$604,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM62,750$601,000thousands by filing date
NATERA INC COM632307104Stock39,539$552,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock4,300$496,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK18,029$442,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM41,074$439,000thousands by filing date
STANDARD BIOTOOLS INC34385P108COM50,455$435,000thousands by filing date
CYMABAY THERAPEUTICS INC23257D103COM47,096$371,000thousands by filing date
INVACARE CORP461203101COMMON STOCK73,902$318,000thousands by filing date
SEASPINE HLDGS CORP81255T108COM15,459$282,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock65,000$267,000thousands by filing date
OPIANT PHARMACEUTICALS INC683750103COM13,901$201,000thousands by filing date
AQUINOX PHARMACEUTICALS INC03842B101COM73,717$159,000thousands by filing date
EPIZYME INC29428V104COM25,449$157,000thousands by filing date
AGILENT TECHNOLOGIES INC COM00846U101Stock1,590$108,000thousands by filing date
Thermo Fisher Scientific Inc.883556102COM475$106,000thousands by filing date
APTARGROUP INC COM038336103Stock1,090$103,000thousands by filing date
CONFORMIS INC20717E101COM136,851$49,000thousands by filing date
MYLAN N VN59465909CALL1,586$36,000thousands by filing date
EIGER BIOPHARMACEUTICALS INC28249U105COM1,020$10,000thousands by filing date
CELGENE CORP151020112RIGHT 12/31/20306,000$3,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001697013-19-000003this filing2019-02-13acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000010 base2023-11-08acceptance time not in the bulk data set